These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15032152)

  • 21. Agitated dementia.
    Geller AS
    Cleve Clin J Med; 1998 Sep; 65(8):442-3; author reply 443-4. PubMed ID: 9769567
    [No Abstract]   [Full Text] [Related]  

  • 22. Treating agitation without drugs.
    Allen LA
    Am J Nurs; 1999 Apr; 99(4):36-41; quiz 42. PubMed ID: 10234322
    [No Abstract]   [Full Text] [Related]  

  • 23. Agitated dementia.
    Chan AS
    Cleve Clin J Med; 1998 Sep; 65(8):442; author reply 443-4. PubMed ID: 9769566
    [No Abstract]   [Full Text] [Related]  

  • 24. Long term care staff beliefs about evidence based practices for the management of dementia and agitation.
    Ayalon L; Arean P; Bornfeld H; Beard R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):118-24. PubMed ID: 18563863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroconvulsive therapy for agitation in Alzheimer disease: a case series.
    Sutor B; Rasmussen KG
    J ECT; 2008 Sep; 24(3):239-41. PubMed ID: 18562945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No way out.
    Cubbin G
    Nurs Stand; 1999 Jul 21-27; 13(44):18-9. PubMed ID: 10531993
    [No Abstract]   [Full Text] [Related]  

  • 28. Sundowning in the Alzheimer's patient.
    Carson VB
    Caring; 2012 Jun; 31(6):52-3. PubMed ID: 22953389
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
    Mahlberg R; Walther S; Eichmann U; Tracik F; Kunz D
    Arch Gerontol Geriatr; 2007; 45(1):19-26. PubMed ID: 16963137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelic variation at the A218C tryptophan hydroxylase polymorphism influences agitation and aggression in Alzheimer's disease.
    Craig D; Hart DJ; Carson R; McIlroy SP; Passmore AP
    Neurosci Lett; 2004 Jun; 363(3):199-202. PubMed ID: 15182943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
    Mauri M; Mancioli A; Rebecchi V; Corbetta S; Colombo C; Bono G
    Acta Neurol Scand; 2006 Aug; 114(2):97-101. PubMed ID: 16867031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects.
    Underwood BR; Fox C
    Evid Based Med; 2014 Oct; 19(5):181. PubMed ID: 24824622
    [No Abstract]   [Full Text] [Related]  

  • 33. [Management of Alzheimer's disease patients and aid devices for their caregivers].
    Verny M
    Psychol Neuropsychiatr Vieil; 2004 Jun; 2(2):158-9. PubMed ID: 15690570
    [No Abstract]   [Full Text] [Related]  

  • 34. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Part VII. Treatment of Neuropsychiatric symptoms in Alzheimer's disease.
    Knopman DS
    Dis Mon; 2000 Nov; 46(11):761-6. PubMed ID: 11130326
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease.
    Bruen PD; McGeown WJ; Shanks MF; Venneri A
    Brain; 2008 Sep; 131(Pt 9):2455-63. PubMed ID: 18669506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on "Cannabinoids for Agitation in Alzheimer's Disease".
    Goveas JS
    Am J Geriatr Psychiatry; 2021 Dec; 29(12):1264-1266. PubMed ID: 33839012
    [No Abstract]   [Full Text] [Related]  

  • 38. Pain and palliative care pharmacotherapy literature summaries and analyses.
    Abernethy AP; Farrell TW
    J Pain Palliat Care Pharmacother; 2009; 23(1):62-8. PubMed ID: 19296357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life for caregivers of people with Alzheimer's disease.
    Vellone E; Piras G; Talucci C; Cohen MZ
    J Adv Nurs; 2008 Jan; 61(2):222-31. PubMed ID: 18186913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?
    Ferrazzoli D; Sica F; Sancesario G
    CNS Neurol Disord Drug Targets; 2013 Jun; 12(4):525-8. PubMed ID: 23574165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.